Fermion-Header

Fermion-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Suzhou Ribo

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

SupplySide West 2021

Participation Not Confirmed

Update your Virtual Booth

Suzhou Ribo Life Science Completes $66 Million C Round for siRNA Portfolio

Lead Product(s): RB-RQ007

Therapeutic Area: Ophthalmology Product Name: Undisclosed

Highest Development Status: Preclinical Product Type: Large molecule

Partner/Sponsor/Collaborator: Capital Venture Capital Fund

Deal Size: $66.0 million Upfront Cash: Undisclosed

Deal Type: Series C Financing April 06, 2020

Details:

The funding is inted boost company's siRNA Portfolio.

<